Skip to Content

Abilify Maintena

In the US, Abilify Maintena (aripiprazole systemic) is a member of the drug class atypical antipsychotics and is used to treat Schizophrenia.

US matches:

UK matches:

Ingredient matches for Abilify Maintena

Aripiprazole

Aripiprazole is reported as an ingredient of Abilify Maintena in the following countries:

  • Austria
  • Canada
  • Croatia (Hrvatska)
  • Finland
  • France
  • Germany
  • Ireland
  • Norway
  • Portugal
  • Sweden
  • United Kingdom
  • United States

Aripiprazole monohydrate (a derivative of Aripiprazole) is reported as an ingredient of Abilify Maintena in the following countries:

  • Israel
  • Switzerland

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide